Price and institutional trades
$5.35−55.6%2Y
JanAprJulOctJanAprJulOct
Holders
$33M · 2026-10-2114.05%
$5.3M · direct 2.09% · indirect 0.17% · 2026-10-212.26%
$5.2M · 2026-10-212.20%
+3 other related parties$1.5M0.63%
Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.
Indirect-only holders
$5.6M · indirect2.38%
$320K · indirect0.14%
No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.
Companies held by HLB Pharmaceutical
Filings
| Filed | Changed | Holder | Change | Before → after | Amount | Avg buy price | |
|---|
| 2026-09-28 | 2026-09-21 | | | 24.31 → 18.97% | −$0 | $4.18 |
| 2026-09-28 | - | | | 2.00 → 1.51% | −$0 | - |
| 2026-08-31 | 2026-08-28 | | | 21.74 → 24.31% | +$6.0M | - |
| 2026-08-27 | - | | | 3.05 → 2.78% | +$688K | - |
| 2026-08-26 | - | | | |
27 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched
